oral semaglutide cardiovascular outcomes soul trial results 2024 2025 Reduces CV Events in T2DM โ (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine ๐งช T2DM + ASCVD/CKD ๐ Oral semaglutide 14 mg vs placebo ๐ Cardiovascular Outcomes Associated with Semaglutide
Description
Patient Consent Informed written consent for the publication of study data was obtained from all participants
Viagra, known generically as sildenafil, is a medication that helps men with erectile dysfunction (ED)
Were excited to introduce a new compounded GLP-1 option , specifically formulated with Vitamin B12 to support energy, metabolism, and tolerability
Additionally, people with a history of heart problems can choose semaglutide or Tirzepatide without concern for high blood pressure or an accelerated heart rate
No dietary supplement is FDA-approved
